Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64701 - 64725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Raloxifene	Approved Investigational	WWC1	23286	downregulated	Raloxifene Hydrochloride results in decreased expression of WWC1 mRNA	5q34	A21106
Raloxifene	Approved Investigational	XPO1	7514	downregulated	Raloxifene Hydrochloride results in decreased expression of XPO1 mRNA	2p15	A20479
Raloxifene	Approved Investigational	XRCC5	7520	downregulated	Raloxifene Hydrochloride results in decreased expression of XRCC5 mRNA	2q35	A20479
Raloxifene	Approved Investigational	ZEB1	6935	downregulated	Raloxifene Hydrochloride results in decreased expression of ZEB1 mRNA	10p11.22	A23827
Raloxifene	Approved Investigational	ZFX	7543	upregulated	Raloxifene Hydrochloride results in increased expression of ZFX mRNA	Xp22.11	A20482
Raloxifene	Approved Investigational	ZMYM2	7750	upregulated	Raloxifene Hydrochloride results in increased expression of ZMYM2 mRNA	13q12.11	A23827
Raloxifene	Approved Investigational	ZNF222	7673	upregulated	Raloxifene Hydrochloride results in increased expression of ZNF222 mRNA	19q13.31	A23827
Raltitrexed	Approved Investigational	ANXA2	302	upregulated	raltitrexed results in increased expression of ANXA2 mRNA	15q22.2	A22640
Raltitrexed	Approved Investigational	FAS	355	upregulated	raltitrexed results in increased expression of FAS mRNA	10q23.31	A23081
Raltitrexed	Approved Investigational	FXYD3	5349	upregulated	raltitrexed results in increased expression of FXYD3 mRNA	19q13.12	A22640
Raltitrexed	Approved Investigational	HSPE1	3336	upregulated	raltitrexed results in increased expression of HSPE1 mRNA	2q33.1	A22640
Raltitrexed	Approved Investigational	SAT1	6303	upregulated	raltitrexed results in increased expression of SAT1 mRNA	Xp22.11	A22640
Raltitrexed	Approved Investigational	TMSB10	9168	upregulated	raltitrexed results in increased expression of TMSB10 mRNA	2p11.2	A22640
Ramipril	Approved Investigational	PDGFA	5154	downregulated	Ramipril results in decreased expression of PDGFA mRNA	7p22.3	A23834
Ramipril	Approved Investigational	PDGFB	5155	downregulated	Ramipril results in decreased expression of PDGFB mRNA	22q13.1	A23834
Rasagiline	Approved Investigational	GDNF	2668	upregulated	rasagiline results in increased expression of GDNF mRNA	5p13.2	A23835
Rebamipide	Approved Investigational	BIRC5	332	downregulated	rebamipide results in decreased expression of BIRC5 mRNA	17q25.3	A23836
Rebamipide	Approved Investigational	CXCL8	3576	downregulated	rebamipide results in decreased expression of CXCL8 mRNA	4q13.3	A23837
Repaglinide	Approved Investigational	CXCL8	3576	downregulated	repaglinide metabolite results in decreased expression of CXCL8 mRNA	4q13.3	A23838
Rescinnamine	Approved	ABCB1	5243	upregulated	rescinnamine results in increased expression of ABCB1 mRNA	7q21.12	A23839
Reserpine	Approved Withdrawn	ABCB1	5243	upregulated	Reserpine results in increased expression of ABCB1 mRNA	7q21.12	A23839
Reserpine	Approved Withdrawn	AKR1B10	57016	upregulated	Reserpine results in increased expression of AKR1B10 mRNA	7q33	A20662
Reserpine	Approved Withdrawn	CCND1	595	downregulated	Reserpine results in decreased expression of CCND1 mRNA	11q13.3	A23840
Reserpine	Approved Withdrawn	CYP2B6	1555	upregulated	[Reserpine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA	19q13.2	A21544
Reserpine	Approved Withdrawn	CYP3A4	1576	upregulated	[Reserpine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA	7q22.1	A21544

Displaying entries 64701 - 64725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability